YOUR BUSINESS AUTHORITY
Springfield, MO
Pfizer Inc. is in talks to buy biotech firm Seagan Inc., people familiar with the matter told The Wall Street Journal.
The deal could be valued at more than $30 billion, the sources said.
The sources said the deal is in the early stages.
Read more from The Wall Street Journal.
Project work in Springfield corridor will continue into 2031.
Thanksgiving staple recalled at Costco
Warren Buffett donates $5.5B worth of Berkshire Hathaway shares
HBA of Greater Springfield executive officer to retire
Transportation officials discuss $471M Forward 44 initiative
Monday Morning Business Leads: Nov. 16, 2026
Former OMB Bank officer placed on probation
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.